Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Stem Cell Transplantation in Refractory/Recurrent NHL and HD
NCT00802113Phase 2Completed
- Sponsor
- Columbia University
- Start
- Jun 2003
- Primary completion
- Oct 2014
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands, Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of fludarabine, busulfan, antithymocyte globulin rabbit in non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL), sponsored by Columbia University. Started Jun 2003; status: completed.
02
Drugs
fludarabinebusulfanantithymocyte globulin rabbit
03
Conditions
non-Hodgkin lymphoma (NHL)Hodgkin lymphoma (HL)
Beyond the preview
Go deeper on NCT00802113.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00802113.